K36 Therapeutics, Inc. ("K36"), a privately held, clinical-stage biotechnology company developing novel targeted therapies for cancers with high unmet medical need, today announced data from its Phase ...

Prostate tumors contain more microplastics than healthy prostate tissue, researchers from New York University Langone Health ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

New research from NYU Langone Health detects microplastics in 9 out of 10 prostate cancer tumours, with levels 2.5× higher ...

Targeted cancer therapies are an expanding field of effective therapeutic approaches. While previous chemotherapy agents indiscriminately killed rapidly proliferating cells, newer “precision medicine” ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...

Scientists have learned that prostate cancers can vary significantly among patients and that there are often differences within each patient's tumor. However, the study published Aug. 28 in Nature ...

A new study from Cold Spring Harbor Laboratory Professor Lloyd Trotman and colleagues, published in Science, shows that menadione significantly slows prostate cancer growth in mice and in ...

Telomir-1 has already been shown in multiple human cell lines to successfully elongate telomeres, raising this theoretical risk. However, this latest study demonstrates that Telomir-1 does not promote ...

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to healthy tissue from patient samples.